Here are relevant reports on : aesthetic-medicine-market
-
Advanced Visualization Market by Type (Enterprise, Standalone), Modality (MRI, CT, PET, Ultrasound, Radiotherapy, Nuclear Medicine), Application (Radiology, Oncology, Neuro), End User (Hospital, ASC, Diagnostic Center) & Region - Global Forecast to 2029
The global advanced visualization market, valued at US$3.36 billion in 2023, stood at US$3.78 billion in 2024 and is projected to advance at a resilient CAGR of 11.7% from 2024 to 2029, culminating in a forecasted valuation of US$6.55 billion by the end of the period. Technological advancements in advanced visualization tools, the rising need for early detection of diseases, and the growing support from government & private organizations are key factors driving the market growth.
- Published: January 2025
- Price: $ 4950
- TOC Available:
-
Europe Artificial Intelligence (AI) in Healthcare Market by Offering (Integrated), Function (Diagnosis, Genomic, Precision Medicine, Radiation, Telehealth, RPM, Immunotherapy, Supply Chain), Application (Clinical), End User (Hospitals) - Forecast to 2030
The Europe Artificial Intelligence (AI) in Healthcare Market, valued at USD 4.20 billion in 2024, stood at USD 6.12 billion in 2025 and is projected to advance at a resilient CAGR of 39.0% from 2025 to 2030, culminating in a forecasted valuation of USD 31.72 billion by the end of the period. This growth is driven by strong regulatory support for digital transformation and the rising adoption of AI-enabled clinical workflows across European health systems.
- Published: December 2025
- Price: $ 4950
- TOC Available:
-
Aesthetic Lasers Market by Type (Standalone (CO2, Er:YAG, Diode, Nd:YAG, Alexandrite, Pulsed-Dye), Multiplatform), Application (Acne, Scars, Tattoo Removal, Varicose Veins), End User (Hospitals, Medical Spa, Private clinics)- Global Forecast to 2021
The aesthetic lasers market size is projected to grow at a CAGR of 10.2%. Major players in this market includes Aerolase (U.S.), Alma Lasers, Ltd. (Israel), Cutera, Inc. (U.S.), Cynosure, Inc. (U.S.), El.En. SpA (Italy), Lumenis Ltd. (Israel), Sciton, Inc. (U.S.), SharpLight Technologies (Israel), Syneron Medical Inc. (Israel), and Solta Medical (U.S.).
- Published: October 2016
- Price: $ 4950
- TOC Available:
-
Delivery Drones Market by Solution (Platform (Fixed Wing, Multirotor, Fixed Wing VTOL), Software (Route Planning & Optimizing, Live Tracking, Camera Vision, Inventory Management, Fleet Management), Infrastructure (Ground Control Station, Charging Station, Landing Pad, Micro-Fulfillment Centre)], End User [Retail & Food (E-Commerce Package Delivery, Restaurant Package Delivery, Store Package Delivery), Postal & Logistics (Postal Delivery, Parcel Delivery), Healthcare & Pharmacy (Medicine Supply, Blood Supply, Organ Transport, Equipment Transport)), Range (Short Range, Medium Range, Long Range), Payload Capacity (<5 Kilograms, 5-10 Kilograms, >10 Kilograms), Speed (>100 Km/Hour, 100-150 Km/Hour, >150 Km/Hour) and Region - Global Forecast to 2030
Exhaustive secondary research was undertaken to obtain information on the delivery drones market, the peer market, and the parent market. The next step was to validate these findings, assumptions, and sizing by industry experts across the value chain through primary research. Both, top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation were used to estimate the size of segments and subsegments.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
US Nuclear Medicine Market by Type (SPECT [Tc99m, I-123, Ga-67], PET [F-18], Alpha Emitters, Beta Emitters [Y-90, Lu-177]), Application (Onco, Neuro), Procedure, End User (Imaging Center, Hospital), Radioisotope, Market Share, Growth - Forecast to 2030
The US Nuclear Medicine market, valued at US$4.19 billion in 2024, stood at US$4.81 billion in 2025 and is projected to advance at a resilient CAGR of 14.7% from 2025 to 2030, culminating in a forecasted valuation of US$9.56 billion by the end of the period. This growth is attributed to the rapid expansion of theranostics and radioligand therapies, growing FDA approval of novel radiopharmaceuticals, and active clinical research at the US hospitals and academic medical centers.
- Published: February 2026
- Price: $ 4950
- TOC Available:
-
North American Nuclear Medicine Market / Radiopharmaceuticals Market Size by Type (Diagnostic (SPECT - Technetium, PET- F-18), Therapeutic (Beta Emitters – I-131, Alpha Emitters, Brachytherapy – Y-90)), Application (Oncology, Cardiology) & Region - Global Forecast to 2024
North american nuclear medicine market growth is primed to transition from $2.2 billion in 2019 to $2.7 billion by 2024, showcasing a strong CAGR of 4.1%. Growth in the market can primarily be attributed to factors such as the increasing incidence and prevalence of cancer & cardiac ailments and initiatives to lessen the demand-supply gap of Mo-99. However, the short half-life of radiopharmaceuticals reduces their potential adoption, while hospital budget cuts and high equipment prices are expected to limit market growth to a certain extent.
- Published: January 2020
- Price: $ 4950
- TOC Available:
-
Nucleic Acid Isolation and Purification Kits Market by Type (DNA, RNA, Total Nucleic Acid, Others), Method (Column, Magnetic Beads, Reagent), Application (Diagnostics, Personalized Medicine), End User (Pharma & Biotech, CROs) – Global Forecast to 2030
The global nucleic acid isolation and purification kits market, valued at US$2.82 billion in 2024, stood at US$3.02 billion in 2025 and is projected to advance at a resilient CAGR of 9.8% from 2025 to 2030, culminating in a forecasted valuation of US$4.82 billion by the end of the period. The growth of the nucleic acid isolation and purification kits market is mainly driven by the growth in molecular diagnostics and sequencing-based testing. Labs are running more PCR/RT-PCR panels, syndromic testing, and oncology and genetic assays. This directly aids in the growth of consumption of extraction kits across routine workflows.
- Published: February 2026
- Price: $ 4950
- TOC Available:
-
Nuclear Medicine Market by Type [SPECT (Tc-99m, I-123, Ga-67), PET (F-18), Alpha Emitters, Beta Emitters (Y-90, Lu-177), Brachytherapy], Application (Oncology, Cardiology, Neurology), Procedure, End User (Imaging Center, Hospital), and Region -Global Forecast to 2030
The global nuclear medicine market, valued at US$9.03 billion in 2024, stood at US$10.41 billion in 2025 and is projected to advance at a resilient CAGR of 15.1% from 2025 to 2030, culminating in a forecasted valuation of US$21.01 billion by the end of the period. The growth of the market is driven by the rising prevalence of cancer and cardiovascular diseases, which is accelerating the demand for diagnostic and therapeutic radiopharmaceuticals and medical radioisotopes.
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
Clinical Analytics Market by Offering (Raw Data, Platform), Source (EHR, Trials, Claims, RWE), Use Case (CDSS, RPM, PHM, R&D, Pharmacovigilance, Precision Medicine, Regulatory), End User (Hospital, Payer, Pharma, Medtech), Region - Global Forecast to 2030
The global clinical analytics market, valued at US$27.65 billion in 2024, stood at US$33.09 billion in 2025 and is projected to advance at a resilient CAGR of 19.7% from 2024 to 2030, culminating in a forecasted valuation of US$81.32 billion by the end of the period.
- Published: October 2025
- Price: $ 4950
- TOC Available:
-
AI in Oncology Market by Player Type (Integrated Suite), Application (Drug Discovery, De Novo Drug Design, Diagnosis, Precision Medicine, Genomic), Technology (CNN, NLP), Cancer Type (Lung), End User (Hospitals, Pharma), & Region - Global Forecast to 2030
The global AI in oncology market, valued at US$1.92 billion in 2023, stood at US$2.45 billion in 2024 and is projected to advance at a resilient CAGR of 29.4% from 2024 to 2030, culminating in a forecasted valuation of US$11.52 billion by the end of the period. The AI in oncology market is experiencing significant growth due to rising investments in the pharmaceutical and biotech companies to develop potential and advance cancer drugs to reduce the growing cancer burden worldwide.
- Published: December 2024
- Price: $ 4950
- TOC Available:
Records 41 to 50 of 50
